Global Sulfonamides Market Research Report 2022 - Market Study Report

Global Sulfonamides Market Research Report 2022

Report Format: PDF | Report ID: 5380744 | Published Date: July 22, 2022

Choose License
Sulfonamides market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Sulfonamides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    Intestinal Absorption
    Intestinal Tract Difficult to Absorb
    External Use
Segment by Application
    Systemic Infection
    Intestinal Infection
    Burn Infection
    Other Infections
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    Pfizer
    Sanofi
    Roche
    Mylan
    Teva
    Bayer
    Abbott
    GlaxoSmithKline
    Boehringer Ingelheim
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Sulfonamides Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Intestinal Absorption
        1.2.3 Intestinal Tract Difficult to Absorb
        1.2.4 External Use
    1.3 Market by Application
        1.3.1 Global Sulfonamides Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Systemic Infection
        1.3.3 Intestinal Infection
        1.3.4 Burn Infection
        1.3.5 Other Infections
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Sulfonamides Market Perspective (2017-2028)
    2.2 Sulfonamides Growth Trends by Region
        2.2.1 Sulfonamides Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Sulfonamides Historic Market Size by Region (2017-2022)
        2.2.3 Sulfonamides Forecasted Market Size by Region (2023-2028)
    2.3 Sulfonamides Market Dynamics
        2.3.1 Sulfonamides Industry Trends
        2.3.2 Sulfonamides Market Drivers
        2.3.3 Sulfonamides Market Challenges
        2.3.4 Sulfonamides Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Sulfonamides Players by Revenue
        3.1.1 Global Top Sulfonamides Players by Revenue (2017-2022)
        3.1.2 Global Sulfonamides Revenue Market Share by Players (2017-2022)
    3.2 Global Sulfonamides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Sulfonamides Revenue
    3.4 Global Sulfonamides Market Concentration Ratio
        3.4.1 Global Sulfonamides Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Sulfonamides Revenue in 2021
    3.5 Sulfonamides Key Players Head office and Area Served
    3.6 Key Players Sulfonamides Product Solution and Service
    3.7 Date of Enter into Sulfonamides Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Sulfonamides Breakdown Data by Type
    4.1 Global Sulfonamides Historic Market Size by Type (2017-2022)
    4.2 Global Sulfonamides Forecasted Market Size by Type (2023-2028)
5 Sulfonamides Breakdown Data by Application
    5.1 Global Sulfonamides Historic Market Size by Application (2017-2022)
    5.2 Global Sulfonamides Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Sulfonamides Market Size (2017-2028)
    6.2 North America Sulfonamides Market Size by Country (2017-2022)
    6.3 North America Sulfonamides Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Sulfonamides Market Size (2017-2028)
    7.2 Europe Sulfonamides Market Size by Country (2017-2022)
    7.3 Europe Sulfonamides Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Sulfonamides Market Size (2017-2028)
    8.2 Asia-Pacific Sulfonamides Market Size by Country (2017-2022)
    8.3 Asia-Pacific Sulfonamides Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Sulfonamides Market Size (2017-2028)
    9.2 Latin America Sulfonamides Market Size by Country (2017-2022)
    9.3 Latin America Sulfonamides Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Sulfonamides Market Size (2017-2028)
    10.2 Middle East & Africa Sulfonamides Market Size by Country (2017-2022)
    10.3 Middle East & Africa Sulfonamides Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Pfizer
        11.1.1 Pfizer Company Detail
        11.1.2 Pfizer Business Overview
        11.1.3 Pfizer Sulfonamides Introduction
        11.1.4 Pfizer Revenue in Sulfonamides Business (2017-2022)
        11.1.5 Pfizer Recent Development
    11.2 Sanofi
        11.2.1 Sanofi Company Detail
        11.2.2 Sanofi Business Overview
        11.2.3 Sanofi Sulfonamides Introduction
        11.2.4 Sanofi Revenue in Sulfonamides Business (2017-2022)
        11.2.5 Sanofi Recent Development
    11.3 Roche
        11.3.1 Roche Company Detail
        11.3.2 Roche Business Overview
        11.3.3 Roche Sulfonamides Introduction
        11.3.4 Roche Revenue in Sulfonamides Business (2017-2022)
        11.3.5 Roche Recent Development
    11.4 Mylan
        11.4.1 Mylan Company Detail
        11.4.2 Mylan Business Overview
        11.4.3 Mylan Sulfonamides Introduction
        11.4.4 Mylan Revenue in Sulfonamides Business (2017-2022)
        11.4.5 Mylan Recent Development
    11.5 Teva
        11.5.1 Teva Company Detail
        11.5.2 Teva Business Overview
        11.5.3 Teva Sulfonamides Introduction
        11.5.4 Teva Revenue in Sulfonamides Business (2017-2022)
        11.5.5 Teva Recent Development
    11.6 Bayer
        11.6.1 Bayer Company Detail
        11.6.2 Bayer Business Overview
        11.6.3 Bayer Sulfonamides Introduction
        11.6.4 Bayer Revenue in Sulfonamides Business (2017-2022)
        11.6.5 Bayer Recent Development
    11.7 Abbott
        11.7.1 Abbott Company Detail
        11.7.2 Abbott Business Overview
        11.7.3 Abbott Sulfonamides Introduction
        11.7.4 Abbott Revenue in Sulfonamides Business (2017-2022)
        11.7.5 Abbott Recent Development
    11.8 GlaxoSmithKline
        11.8.1 GlaxoSmithKline Company Detail
        11.8.2 GlaxoSmithKline Business Overview
        11.8.3 GlaxoSmithKline Sulfonamides Introduction
        11.8.4 GlaxoSmithKline Revenue in Sulfonamides Business (2017-2022)
        11.8.5 GlaxoSmithKline Recent Development
    11.9 Boehringer Ingelheim
        11.9.1 Boehringer Ingelheim Company Detail
        11.9.2 Boehringer Ingelheim Business Overview
        11.9.3 Boehringer Ingelheim Sulfonamides Introduction
        11.9.4 Boehringer Ingelheim Revenue in Sulfonamides Business (2017-2022)
        11.9.5 Boehringer Ingelheim Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Sulfonamides Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Intestinal Absorption Table 3. Key Players of Intestinal Tract Difficult to Absorb Table 4. Key Players of External Use Table 5. Global Sulfonamides Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Sulfonamides Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Sulfonamides Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Sulfonamides Market Share by Region (2017-2022) Table 9. Global Sulfonamides Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Sulfonamides Market Share by Region (2023-2028) Table 11. Sulfonamides Market Trends Table 12. Sulfonamides Market Drivers Table 13. Sulfonamides Market Challenges Table 14. Sulfonamides Market Restraints Table 15. Global Sulfonamides Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Sulfonamides Market Share by Players (2017-2022) Table 17. Global Top Sulfonamides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sulfonamides as of 2021) Table 18. Ranking of Global Top Sulfonamides Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Sulfonamides Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Sulfonamides Product Solution and Service Table 22. Date of Enter into Sulfonamides Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Sulfonamides Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Sulfonamides Revenue Market Share by Type (2017-2022) Table 26. Global Sulfonamides Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Sulfonamides Revenue Market Share by Type (2023-2028) Table 28. Global Sulfonamides Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Sulfonamides Revenue Market Share by Application (2017-2022) Table 30. Global Sulfonamides Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Sulfonamides Revenue Market Share by Application (2023-2028) Table 32. North America Sulfonamides Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Sulfonamides Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Sulfonamides Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Sulfonamides Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Sulfonamides Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Sulfonamides Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Sulfonamides Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Sulfonamides Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Sulfonamides Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Sulfonamides Market Size by Country (2023-2028) & (US$ Million) Table 42. Pfizer Company Detail Table 43. Pfizer Business Overview Table 44. Pfizer Sulfonamides Product Table 45. Pfizer Revenue in Sulfonamides Business (2017-2022) & (US$ Million) Table 46. Pfizer Recent Development Table 47. Sanofi Company Detail Table 48. Sanofi Business Overview Table 49. Sanofi Sulfonamides Product Table 50. Sanofi Revenue in Sulfonamides Business (2017-2022) & (US$ Million) Table 51. Sanofi Recent Development Table 52. Roche Company Detail Table 53. Roche Business Overview Table 54. Roche Sulfonamides Product Table 55. Roche Revenue in Sulfonamides Business (2017-2022) & (US$ Million) Table 56. Roche Recent Development Table 57. Mylan Company Detail Table 58. Mylan Business Overview Table 59. Mylan Sulfonamides Product Table 60. Mylan Revenue in Sulfonamides Business (2017-2022) & (US$ Million) Table 61. Mylan Recent Development Table 62. Teva Company Detail Table 63. Teva Business Overview Table 64. Teva Sulfonamides Product Table 65. Teva Revenue in Sulfonamides Business (2017-2022) & (US$ Million) Table 66. Teva Recent Development Table 67. Bayer Company Detail Table 68. Bayer Business Overview Table 69. Bayer Sulfonamides Product Table 70. Bayer Revenue in Sulfonamides Business (2017-2022) & (US$ Million) Table 71. Bayer Recent Development Table 72. Abbott Company Detail Table 73. Abbott Business Overview Table 74. Abbott Sulfonamides Product Table 75. Abbott Revenue in Sulfonamides Business (2017-2022) & (US$ Million) Table 76. Abbott Recent Development Table 77. GlaxoSmithKline Company Detail Table 78. GlaxoSmithKline Business Overview Table 79. GlaxoSmithKline Sulfonamides Product Table 80. GlaxoSmithKline Revenue in Sulfonamides Business (2017-2022) & (US$ Million) Table 81. GlaxoSmithKline Recent Development Table 82. Boehringer Ingelheim Company Detail Table 83. Boehringer Ingelheim Business Overview Table 84. Boehringer Ingelheim Sulfonamides Product Table 85. Boehringer Ingelheim Revenue in Sulfonamides Business (2017-2022) & (US$ Million) Table 86. Boehringer Ingelheim Recent Development Table 87. Research Programs/Design for This Report Table 88. Key Data Information from Secondary Sources Table 89. Key Data Information from Primary Sources List of Figures Figure 1. Global Sulfonamides Market Share by Type: 2021 VS 2028 Figure 2. Intestinal Absorption Features Figure 3. Intestinal Tract Difficult to Absorb Features Figure 4. External Use Features Figure 5. Global Sulfonamides Market Share by Application in 2021 & 2028 Figure 6. Systemic Infection Case Studies Figure 7. Intestinal Infection Case Studies Figure 8. Burn Infection Case Studies Figure 9. Other Infections Case Studies Figure 10. Sulfonamides Report Years Considered Figure 11. Global Sulfonamides Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Sulfonamides Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Sulfonamides Market Share by Region: 2021 VS 2028 Figure 14. Global Sulfonamides Market Share by Players in 2021 Figure 15. Global Top Sulfonamides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sulfonamides as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Sulfonamides Revenue in 2021 Figure 17. North America Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. North America Sulfonamides Market Share by Country (2017-2028) Figure 19. United States Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Sulfonamides Market Share by Country (2017-2028) Figure 23. Germany Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. France Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. U.K. Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Italy Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Russia Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Nordic Countries Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Sulfonamides Market Share by Region (2017-2028) Figure 31. China Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Japan Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. South Korea Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Southeast Asia Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. India Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Australia Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Sulfonamides Market Share by Country (2017-2028) Figure 39. Mexico Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Brazil Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Sulfonamides Market Share by Country (2017-2028) Figure 43. Turkey Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Saudi Arabia Sulfonamides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Pfizer Revenue Growth Rate in Sulfonamides Business (2017-2022) Figure 46. Sanofi Revenue Growth Rate in Sulfonamides Business (2017-2022) Figure 47. Roche Revenue Growth Rate in Sulfonamides Business (2017-2022) Figure 48. Mylan Revenue Growth Rate in Sulfonamides Business (2017-2022) Figure 49. Teva Revenue Growth Rate in Sulfonamides Business (2017-2022) Figure 50. Bayer Revenue Growth Rate in Sulfonamides Business (2017-2022) Figure 51. Abbott Revenue Growth Rate in Sulfonamides Business (2017-2022) Figure 52. GlaxoSmithKline Revenue Growth Rate in Sulfonamides Business (2017-2022) Figure 53. Boehringer Ingelheim Revenue Growth Rate in Sulfonamides Business (2017-2022) Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research

Budget constraint? Get in touch to get special pricing offers


Request For Discount

Why Market Study Report?


  • Best Price for Reports
  • Large Report Database
  • Easily Customize Reports
  • 24/7 Email & Phone Support

Can't find what you're looking for about this report?

Submit Query

Go to contact form

Phone Number

1-302-273-0910
Chat with us